Author |   Angela Demichele, MD, MSCE Assistant Professor of Medicine

Articles

Optimizing Outcomes With Bevacizumab by Better Targeting Patients and Tumors

April 09, 2009

Numerous preclinical and clinical studies have demonstrated a role for angiogenesis in the growth and progression of breast cancer. Elevated vascular endothelial growth factor (VEGF) levels have been demonstrated in association with poor outcomes, and thus, this finding is an attractive target for therapeutic intervention.